Abbott Laboratories reported Q2 revenue of $12.59 billion (+13% YoY), beating estimates and raising its full-year EPS guidance. Analysts hiked price targets in response, with BTIG going to $134, reflecting confidence in its diversified healthcare portfolio and pipeline. UnitedHealth also delivered a massive EPS beat, but Abbott’s medtech and diagnostics momentum carries particular relevance for the biopharma sector.
Source: benzinga.com
President Trump’s accounts heavily traded health care stocks in early 2026, with UnitedHealth and Humana leading gains. The activity gives insight into which health care sectors are recovering after a turbulent 2025.
President Trump’s financial disclosure shows massive trading activity, with 377 health care trades totaling up to $37 million. For investors, the performance dispersion among his top picks offers a case study in whether to mimic political insider trades.
Source: Trade Counts And Dollar Ranges Are From The President's Financial Disclosure || Year-To-Date Prices (us) · Trade Counts And Dollar Ranges Are From The President's Financial Disclosure || Year-To-Date Prices (us)